Cover Image
市場調查報告書

Advanced Accelerator Applications SA的產品平台分析

Advanced Accelerator Applications SA - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 327903
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Advanced Accelerator Applications SA的產品平台分析 Advanced Accelerator Applications SA - Product Pipeline Review - 2015
出版日期: 2015年02月28日 內容資訊: 英文 24 Pages
簡介

Advanced Accelerator Applications SA是總公司在法國,製造PET放射性醫藥品及商品化專門的放射性醫藥品企業。以腫瘤、神經學、心血管系統疾病、感染疾病、發炎等疾病為對象,進行分子影像診斷藥及治療藥的研究開發、製造、流通。

本報告提供Advanced Accelerator Applications SA 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標靶、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Advanced Accelerator Applications SA 基本資料

  • Advanced Accelerator Applications SA 概要
  • 主要資訊
  • 企業資料

Advanced Accelerator Applications SA :R&D概要

  • 主要的治療範圍

Advanced Accelerator Applications SA :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Advanced Accelerator Applications SA :開發中產品概況

  • 後期階段產品開發中產品
    • 第三階段的產品/聯合治療模式
  • 在臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Advanced Accelerator Applications SA :藥物簡介

  • Lutathera
  • FabOvar
  • Theranean

Advanced Accelerator Applications SA :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Advanced Accelerator Applications SA :最近的開發平台資訊

Advanced Accelerator Applications SA :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

目錄
Product Code: GMDHC06811CDB

Summary

Global Markets Direct's, 'Advanced Accelerator Applications SA - Product Pipeline Review - 2015', provides an overview of the Advanced Accelerator Applications SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Advanced Accelerator Applications SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Advanced Accelerator Applications SA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Advanced Accelerator Applications SA's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Advanced Accelerator Applications SA's pipeline products

Reasons to buy

  • Evaluate Advanced Accelerator Applications SA's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Advanced Accelerator Applications SA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Advanced Accelerator Applications SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Advanced Accelerator Applications SA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advanced Accelerator Applications SA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Advanced Accelerator Applications SA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Advanced Accelerator Applications SA Snapshot
    • Advanced Accelerator Applications SA Overview
    • Key Information
    • Key Facts
  • Advanced Accelerator Applications SA - Research and Development Overview
    • Key Therapeutic Areas
  • Advanced Accelerator Applications SA - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Advanced Accelerator Applications SA - Pipeline Products Glance
    • Advanced Accelerator Applications SA - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Advanced Accelerator Applications SA - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Advanced Accelerator Applications SA - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Advanced Accelerator Applications SA - Drug Profiles
  • Lutathera
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FabOvar
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Theranean
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Advanced Accelerator Applications SA - Pipeline Analysis
    • Advanced Accelerator Applications SA - Pipeline Products by Target
    • Advanced Accelerator Applications SA - Pipeline Products by Route of Administration
    • Advanced Accelerator Applications SA - Pipeline Products by Molecule Type
    • Advanced Accelerator Applications SA - Pipeline Products by Mechanism of Action
  • Advanced Accelerator Applications SA - Recent Pipeline Updates
  • Advanced Accelerator Applications SA - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Advanced Accelerator Applications SA, Key Information
  • Advanced Accelerator Applications SA, Key Facts
  • Advanced Accelerator Applications SA - Pipeline by Indication, 2015
  • Advanced Accelerator Applications SA - Pipeline by Stage of Development, 2015
  • Advanced Accelerator Applications SA - Monotherapy Products in Pipeline, 2015
  • Advanced Accelerator Applications SA - Phase III, 2015
  • Advanced Accelerator Applications SA - Phase II, 2015
  • Advanced Accelerator Applications SA - Preclinical, 2015
  • Advanced Accelerator Applications SA - Pipeline by Target, 2015
  • Advanced Accelerator Applications SA - Pipeline by Route of Administration, 2015
  • Advanced Accelerator Applications SA - Pipeline by Molecule Type, 2015
  • Advanced Accelerator Applications SA - Pipeline Products by Mechanism of Action, 2015
  • Advanced Accelerator Applications SA - Recent Pipeline Updates, 2015
  • Advanced Accelerator Applications SA, Other Locations
  • Advanced Accelerator Applications SA, Subsidiaries

List of Figures

  • Advanced Accelerator Applications SA - Pipeline by Top 10 Indication, 2015
  • Advanced Accelerator Applications SA - Pipeline by Stage of Development, 2015
  • Advanced Accelerator Applications SA - Monotherapy Products in Pipeline, 2015
  • Advanced Accelerator Applications SA - Pipeline by Top 10 Target, 2015
  • Advanced Accelerator Applications SA - Pipeline by Top 10 Molecule Type, 2015
  • Advanced Accelerator Applications SA - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top